Clinical trial
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
NCT05469607 is registered in ClinicalTrials.gov with Austin Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
- Lead sponsor
- Austin Health
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 8, 2022
- Completion date
- July 31, 2028
- Enrollment
- 13 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.